GlassScriptPhysician profile
Suresh Kankanala
NPI 1922211697
$2,715.80
in general payments reported to CMS, 2019-2025
27 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.00 · 2021: $242 · 2022: $305 · 2023: $322 · 2024: $639 · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,135 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,135.39 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $530.21 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $401.76 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $242.28 | 2021-2025 | Airsupra, Breztri |
| Amgen INC. | $193.30 | 2025 | Repatha, Otezla |
| Lilly USA, LLC | $186.07 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.80 | 2021-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $117.55 | 2021-2024 | Freestyle Libre, Proclaim |
| Abbvie INC. | $110.75 | 2023-2025 | |
| Corcept Therapeutics | $108.49 | 2025 | Korlym |
| Lundbeck LLC | $93.88 | 2024-2025 | Vyepti |
| Inari Medical, INC. | $76.33 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $75.94 | 2025 | Assure Wcd |
| Dexcom, INC. | $52.86 | 2022-2023 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $48.16 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.43 | 2023-2024 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $32.81 | 2022-2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $26.10 | 2025 | Gvoke Hypopen |
| Bardy Diagnostics, INC. | $25.00 | 2022 | |
| Hologic Sales and Service, LLC | $23.23 | 2025 | Aptima |
| Globus Medical, INC. | $21.96 | 2025 | Senza |
| Gilead Sciences, INC. | $21.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2024 | |
| Astellas Pharma US INC | $19.61 | 2025 | Veozah |
| Baxter Healthcare | $17.16 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $16.85 | 2025 | |
| Organon LLC | $14.23 | 2025 | Nexplanon |
| Genentech USA, INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Kankanala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.